Peptoid Based Slide Coatings For Disease Detection Via Elisa Microarray Analysis,
2012
University of Arkansas, Fayetteville
Peptoid Based Slide Coatings For Disease Detection Via Elisa Microarray Analysis, Melissa Lea Hebert
Graduate Theses and Dissertations
Poly-N-substituted glycines (peptoids) are a very versatile family of synthetic molecules that can be customized for any number of applications. In this study, we chose to use peptoids as a foundation for sandwich ELISA microarray analysis with a long term goal of creating an early detection device for complex diseases such as cancer. The peptoids were designed to self-assemble into microspheres to be used in coatings on the surface of the microarray substrates to increase the surface area available for antibody attachment. This increased antibody density would lead to an increase in the microarray analysis sensitivity and dynamic range. Studies …
Synergistic Effects Of Nanosecond Pulsed Electric Fields Combined With Low Concentration Of Gemcitabine On Human Oral Squamous Cell Carcinoma In Vitro,
2012
Old Dominion University
Synergistic Effects Of Nanosecond Pulsed Electric Fields Combined With Low Concentration Of Gemcitabine On Human Oral Squamous Cell Carcinoma In Vitro, Jing Wang, Jinsong Guo, Shan Wu, Hongqing Feng, Shujun Sun, Jie Pan, Jue Zhang, Stephen J. Beebe
Bioelectrics Publications
Treatment of cancer often involves uses of multiple therapeutic strategies with different mechanisms of action. In this study we investigated combinations of nanosecond pulsed electric fields (nsPEF) with low concentrations of gemcitabine on human oral cancer cells. Cells (Cal-27) were treated with pulse parameters (20 pulses, 100 ns in duration, intensities of 10, 30 and 60 kV/cm) and then cultured in medium with 0.01 mu g/ml gemcitabine. Proliferation, apoptosis/necrosis, invasion and morphology of those cells were examined using MTT, flow cytometry, clonogenics, transwell migration and TEM assay. Results show that combination treatments of gemcitabine and nsPEFs exhibited significant synergistic activities …
Role Of Stat3 In Keratinocyte Stem Cells During Skin Tumorigenesis,
2012
The University of Texas Graduate School of Biomedical Sciences at Houston
Role Of Stat3 In Keratinocyte Stem Cells During Skin Tumorigenesis, Dharanija Rao
Dissertations and Theses (Open Access)
STATs play crucial roles in a wide variety of biological functions, including development, proliferation, differentiation, migration and in cancer development. In the present study, we examined the impact of Stat3 deletion or activation on behavior of keratinocytes, including keratinocyte stem cells (KSCs). Deletion of Stat3 specifically in the bulge region of the hair follicle using K15.CrePR1 X Stat3fl/fl mice led to decreased tumor development by altering survival of bulge region KSCs. To further understand the role of KSCs in skin tumorigenesis, K5.Stat3C transgenic (Tg) mice which express a constitutively active/dimerized form of Stat3 called Stat3C via the bovine keratin …
Platelets And Anti-Angiogenic Resistance In Ovarian Carcinoma,
2012
The University of Texas Graduate School of Biomedical Sciences at Houston
Platelets And Anti-Angiogenic Resistance In Ovarian Carcinoma, Justin N. Bottsford-Miller
Dissertations and Theses (Open Access)
Background: Resistance to targeted anti-angiogenic therapy is a growing clinical concern given the disappointing clinical impact of anti-angiogenic. Platelets represent a component of the tumor microenvironment that are implicated in metastasis and represent a significant reservoir of angiogenic regulators. Thrombocytosis has been shown to be caused by malignancy and associated with adverse clinical outcomes, however the causal connections between these associations remain to be identified.
Materials and Methods: Following IRB approval, patient data were collected on patients from four U.S. centers and platelet levels through and after therapy were considered as indicators of recurrence of disease. In vitro effects of …
Optimizing Protocols For The Derivation Of Primary Cultures From Mammalian Tissue,
2012
Department of Biological Sciences, University of Texas at El Paso
Optimizing Protocols For The Derivation Of Primary Cultures From Mammalian Tissue, Eduardo Ramirez, Natzidielly Lerma, Paloma Valenzuela, Karla Parra, Courteny L. Becerril, Irving Miramontes, Howard West, Cynthia Rodriguez, Giulio Francia
COURI Symposium Abstracts, Summer 2012
The isolation of primary cell cultures from fresh mammalian tissue is a major interest of our laboratory. Thus, the ability to generate cancer cell lines from cancer tissue, or to generate non-malignant cultures form the host stroma surrounding a tumor, allows us to develop new laboratory models to study the behavior of cancer cells and its microenvironment. We report our proof of principle study on optimizing the derivation of primary culture, using rat tissues as a model. Thus, rat kidney and rat skin samples were isolated, minced with surgical blades, and then incubated with an enzyme digestion cocktail (Collagenase III- …
Messenger Mrna Analysis As A Means To Identify Mechanisms Of Cancer Drug Resistance,
2012
Department of Biological Sciences, University of Texas at El Paso
Messenger Mrna Analysis As A Means To Identify Mechanisms Of Cancer Drug Resistance, Courtney L. Becerril, Irving Miramontes, Jiselle Del Cid, Natzidielly Lerma, Karla Parra, Eduardo D. Ramirez, Howard West, Paloma Valenzuela, Cynthia Rodriguez, Giulio Francia
COURI Symposium Abstracts, Summer 2012
On principal approach to identify the mechanisms by which cancers escape from anti-cancer therapies is the analysis of messenger RNAs (mRNAs) in those tumor cells that survive treatment. Thus, by studying Her-2 positive human breast tumor cells that survived anti-Her-2 based therapies (i.e., using anti-Her-2 antibody) we observed the 3-fold or greater overexpression of Vascular Endothelial Growth Factor (VEGF) mRNA. Similarly, by studying the mRNAs of tumor cell cultures resistant to chemotherapy (such as cisplatin), we found that low levels of mRNAs for DNA mismatch repair genes correlates with drug resistance. These results suggest that two possible strategies of sensitizing …
Protein Expression Analysis Of Cell Lines Derived From Drug Resistant Tumors,
2012
Department of Biological Sciences, The University of Texas at El Paso
Protein Expression Analysis Of Cell Lines Derived From Drug Resistant Tumors, Paloma Valenzuela, Karla Parra, Natzidielly Lerma, Courtney Becerril, Eduardo Ramirez, Irving Miramontes, Howard West, Cynthia Rodriguez, Yang Li, Jianying Zhang, Giulio Francia
COURI Symposium Abstracts, Summer 2012
There are a number of effective treatments for breast cancer, including chemotherapy and targeted strategies such as the use of the Her-2 targeting drugs lapatinib and trastuzumab. However, in a number of cases, tumors that initially respond to therapy eventually develop drug resistance, leading to the relapse of the disease. By studying protein levels in different drug resistant variants, we have observed two mechanisms by which drug resistance may develop. Thus, some Her-2 human breast cancer cells (e.g., MDA-MB-231H2N) treated with the clinically used trastuzumab agent, can escape therapy by shedding, or losing, the target Her-2 protein. Similarly, EMT-6 mouse …
Evaluating Ceramide Analogs, 5-Lipoxygenase Expression, And Lipid Raft Biology In Breast Cancer,
2012
Department of Biological Sciences, University of Texas at El Paso
Evaluating Ceramide Analogs, 5-Lipoxygenase Expression, And Lipid Raft Biology In Breast Cancer, Jiselle Del Cid, Debarshi Roy, Atasi De Chatterjee, Karla Parra, Howard West, Guido Bocci, Cynthia Rodriguez, Siddhartha Das, Giulio Francia
COURI Symposium Abstracts, Summer 2012
To investigate the role of lipid rafts in the biology of breast cancer cells, we designed a human breast cancer cell line panel (using MCF-7, MDA-MB-231, and HCC1419 cells) to test the anti-tumor impact of new ceramide analogs. Our aim is to use such a screening to ultimately develop a project to investigate the role of 5-lipoxygenase enzyme on the behavior of breast cancer cells, including MDA-MB231 that express 5-lipoxygenase and MCF-7 which do not, and to ask whether ceramide analogs can have an impact on this behavior.
To date, we have evaluated three ceramide analogs, termed C2, C6 and …
Development Of New Models To Study Human Her-2 Positive Breast Cancer,
2012
Department of Biological Sciences, University of Texas at El Paso.
Development Of New Models To Study Human Her-2 Positive Breast Cancer, Howard J. West, Karla Parra, Natzidielly Lerma, Paloma Valenzuela, Eduardo Ramirez, Courtney L. Becerril, Irving Miramontes, Elizabeth Gamez, Cynthia Rodriguez, Guido Bocci, Giulio Francia
COURI Symposium Abstracts, Summer 2012
To study the evolution of human Her-2 positive breast cancer, we evaluated a model of three dimensional spheroid co-culture using H2N human breast cancer cells that express high amounts of Her-2 protein, with the Her-2 negative MDA-231 cells. Human HCC1419, which can form compact spheroids, were used as controls. In tissue culture plates, H2N cells were found to have a doubling rate of about 48 hours, compared to around 144 hours for MDA231. Since H2N cells were engineered to express a fluorescent protein, we could note that these cells did not immediately overgrow the non-fluorescent MDA231 cells in a mixed …
Cytotoxic Effects Of Creosote (Larrea Tridentata) Plant Extracts On Human Lymphoma Cells Lines,
2012
Departamento de Biología, Universidad de Puerto Rico en Arecibo
Cytotoxic Effects Of Creosote (Larrea Tridentata) Plant Extracts On Human Lymphoma Cells Lines, Emanuel Cordero, Yahaira Santiago, Carolina Lema, Armando Varela-Ramirez, Renato J Aguilera
COURI Symposium Abstracts, Summer 2012
Larrea tridentata also known as Creosote is a North American shrub, whose leave extracts are proposed to contain anti-cancer properties. The main metabolite in this plant is the nordihydroguaiaretic acid (NDGA) has been shown to have anti-neoplastic, anti-viral and anti-inflammatory properties. NDGA is a strong anti-oxidant that can scavenge or inhibit reactive oxygen spices production, stimulate nitric oxide production, increase immune function, enhance central nervous system function, and prevent cardiovascular or other diseases. Although extracts from this plant are currently used in Mexico as an herbal medicine, the Food and Drug Administration and Health Canada have issued health hazard warming …
In Vitro Evaluation Of Human Her2-Positive Breast Cancer Cells,
2012
Department of Biological Sciences, University of Texas at El Paso
In Vitro Evaluation Of Human Her2-Positive Breast Cancer Cells, Karla Parra, Howard West, Paloma Valenzuela, Eduardo D. Ramirez, Natzidielly Lerma, Courtney Becerril, Irving Miramontes, Cynthia M. Rodriguez, Guido Bocci, Giulio Francia
COURI Symposium Abstracts, Summer 2012
One in four cases of breast cancer shows over expression of the Her-2 protein, and there is an urgent need to improve therapies for this disease. We have evaluated two Her-2 positive human breast cancer cell lines, MDA-231H2N and HCC1419. MDA-231 human breast cancer cell, which are Her-2 negative, were used as a control. The cell lines were evaluated in vitro for their relative growth rate, their growth under reduced (i.e. 3% serum) conditions, or as spheroid cultures, and for their sensitivity to drugs such as ceramide analogs and tyrosine kinase inhibitors (i.e. CLM3, CLM29, and CLM94) that are being …
The Human Phosphotyrosine Signaling Network: Evolution And Hotspots Of Hijacking In Cancer.,
2012
University of Western Ontario
The Human Phosphotyrosine Signaling Network: Evolution And Hotspots Of Hijacking In Cancer., Lei Li, Chabane Tibiche, Cong Fu, Tomonori Kaneko, Michael F. Moran, Martin Schiller, Shawn Shun-Cheng Li, Edwin Wang
Life Sciences Faculty Research
Phosphotyrosine (pTyr) signaling, which plays a central role in cell-cell and cell-environment interactions, has been considered to be an evolutionary innovation in multicellular metazoans. However, neither the emergence nor the evolution of the human pTyr signaling system is currently understood. Tyrosine kinase (TK) circuits, each of which consists of a TK writer, a kinase substrate, and a related reader, such as Src homology (SH) 2 domains and pTyr-binding (PTB) domains, comprise the core machinery of the pTyr signaling network. In this study, we analyzed the evolutionary trajectories of 583 literature-derived and 50,000 computationally predicted human TK circuits in 19 representative …
Melanoma Induction By Ultraviolet A But Not Ultraviolet B Radiation Requires Melanin Pigment,
2012
George Washington University
Melanoma Induction By Ultraviolet A But Not Ultraviolet B Radiation Requires Melanin Pigment, Frances P. Noonan, M. Raza Zaidi, Agnieszka Wolnicka-Glubisz, Miriam R. Anver, Jesse Bahn, Anastas Popratiloff, +9 Additional Authors
Anatomy and Regenerative Biology Faculty Publications
Malignant melanoma of the skin (CMM) is associated with ultraviolet radiation exposure, but the mechanisms and even the wavelengths responsible are unclear. Here we use a mammalian model to investigate melanoma formed in response to precise spectrally defined ultraviolet wavelengths and biologically relevant doses. We show that melanoma induction by ultraviolet A (320–400 nm) requires the presence of melanin pigment and is associated with oxidative DNA damage within melanocytes. In contrast, ultraviolet B radiation (280–320 nm) initiates melanoma in a pigment-independent manner associated with direct ultraviolet B DNA damage. Thus, we identified two ultraviolet wavelength-dependent pathways for the induction of …
Interleukin-1Β Mediates Metalloproteinase-Dependent Renal Cell Carcinoma Tumor Cell Invasion Through The Activation Of Ccaat Enhancer Binding Protein Β,
2012
Dartmouth College
Interleukin-1Β Mediates Metalloproteinase-Dependent Renal Cell Carcinoma Tumor Cell Invasion Through The Activation Of Ccaat Enhancer Binding Protein Β, Brenda L. Petrella, Matthew P. P. Vincenti
Dartmouth Scholarship
Effective treatment of metastatic renal cell carcinoma (RCC) remains a major medical concern, as these tumors are refractory to standard therapies and prognosis is poor. Although molecularly targeted therapies have shown some promise in the treatment of this disease, advanced RCC tumors often develop resistance to these drugs. Dissecting the molecular mechanisms underlying the progression to advanced disease is necessary to design alternative and improved treatment strategies. Tumor-associated macrophages (TAMs) found in aggressive RCC tumors produce a variety of inflammatory cytokines, including interleukin-1 b (IL-1b). Moreover, the presence of TAMs and high serum levels of IL-1b in RCC patients correlate …
Pv1 Down-Regulation Via Shrna Inhibits The Growth Of Pancreatic Adenocarcinoma Xenografts,
2012
Dartmouth College
Pv1 Down-Regulation Via Shrna Inhibits The Growth Of Pancreatic Adenocarcinoma Xenografts, Sophie J. Deharvengt, Dan Tse, Olga Sideleva, Caitlin Mcgarry, Jason R. Gunn, Daniel S. Longnecker, Catherine Carriere, Radu V. Stan
Dartmouth Scholarship
PV1 is an endothelial-specific protein with structural roles in the formation of diaphragms in endothelial cells of normal vessels. PV1 is also highly expressed on endothelial cells of many solid tumours. On the basis of in vitro data, PV1 is thought to actively participate in angiogenesis. To test whether or not PV1 has a function in tumour angiogenesis and in tumour growth in vivo, we have treated pancreatic tumour-bearing mice by single-dose intratumoural delivery of lentiviruses encoding for two different shRNAs targeting murine PV1. We find that PV1 down-regulation by shRNAs inhibits the growth of established tumours derived from two …
Oxaliplatin And Oxaliplatin Derivatives: Synthesis, Characterization, And Reactivity With Biologically Relevant Ligands,
2012
Western Kentucky University
Oxaliplatin And Oxaliplatin Derivatives: Synthesis, Characterization, And Reactivity With Biologically Relevant Ligands, Amy Poynter
Mahurin Honors College Capstone Experience/Thesis Projects
Oxaliplatin is a third generation anticancer drug that has proven to be successful in fighting ovarian and testicular cancer. We are interested in determining how oxaliplatin and oxaliplatin derivatives interact with proteins, as well as how that interaction is affected by the size and shape of these platinum compounds. We have synthesized oxaliplatin as it is used in cancer treatment, as well as similar platinum compounds with the same diaminocyclohexane ligand as oxaliplatin but with additional bulk added to the nitrogen atoms. We are reacting oxaliplatin with key amino acids, including methionine, and will be comparing the kinetics of this …
Effect Of Combining Bcl-2 Inhibition And Radiation On Apoptotic Cell Death In Human Breast Cancer Cell Lines As Determined By Clonogenic Assay And Western Blots,
2012
Syracuse University
Effect Of Combining Bcl-2 Inhibition And Radiation On Apoptotic Cell Death In Human Breast Cancer Cell Lines As Determined By Clonogenic Assay And Western Blots, Amari Sasha Howard
Renée Crown University Honors Thesis Projects - All
Cancer is a group of diseases characterized by abnormal control of cell growth and cell survival. Current treatment for cancer employs a combination of modalities including surgery, radiation, chemotherapeutic drugs, and immunotherapy. Our lab focuses on personalized medicine and treatments that can specifically target molecular features of a tumor as presented by the particular patient being treated. Cancers often exhibit an over-expression or under-expression of certain proteins that play a large role in regulating the process of apoptosis, which is programmed cell death. This study focuses on proposing drug treatment for cancer that is personalized in that it targets a …
Microrna Regulation Of Prostate Cancer Stem/Progenitor Cells And Prostate Cancer Development,
2012
The University of Texas Graduate School of Biomedical Sciences at Houston
Microrna Regulation Of Prostate Cancer Stem/Progenitor Cells And Prostate Cancer Development, Can Liu
Dissertations and Theses (Open Access)
Most human tumors contain a population of cells with stem cell properties, called cancer stem cells (CSCs), which are believed to be responsible for tumor establishment, metastasis, and resistance to clinical therapy. It’s crucial to understand the regulatory mechanisms unique to CSCs, so that we may design CSC-specific therapeutics. Recent discoveries of microRNA (miRNA) have provided a new avenue in understanding the regulatory mechanisms of cancer. However, how miRNAs may regulate CSCs is still poorly understood. Here, we present miRNA expression profiling in six populations of prostate cancer (PCa) stem/progenitor cells that possess distinct tumorigenic properties. Six miRNAs were identified …
14-3-3 Zeta Overexpression Serves As A Novel Molecular Switch Turning Tgf-Beta From Tumor Suppressor To Tumor Promoter,
2012
The University of Texas Graduate School of Biomedical Sciences at Houston
14-3-3 Zeta Overexpression Serves As A Novel Molecular Switch Turning Tgf-Beta From Tumor Suppressor To Tumor Promoter, Jia Xu
Dissertations and Theses (Open Access)
TGF-β plays an important role in differentiation and tissue morphogenesis as well as cancer progression. However, the role of TGF-β in cancer is complicate. TGF-β has primarily been recognized as tumor suppressor, because it can directly inhibit cell proliferation of normal and premalignant epithelial cell. However, in the last stage of tumor progression, TGF-β functions as tumor promoter to enhance tumor cells metastatic dissemination and expands metastatic colonies. Currently, the mechanism of how TGF-β switches its role from tumor suppressor to promoter still remains elusive. Here we identify that overexpression of 14-3-3ζ inhibits TGF-β’s cell cytostatic program through destabilizing p53 …
Elucidating The Igfbp2 Signaling Pathway In Glioma Development And Progression,
2012
The Univeristy of Texas Graduate School of Biomedical Sciences at Houston
Elucidating The Igfbp2 Signaling Pathway In Glioma Development And Progression, Kristen M. Holmes
Dissertations and Theses (Open Access)
Diffuse gliomas are highly lethal central nervous system malignancies which, unfortunately, are the most common primary brain tumor and also the least responsive to the very few therapeutic modalities currently available to treat them. IGFBP2 is a newly recognized oncogene that is operative in multiple cancer types, including glioma, and shows promise for a targeted therapeutic approach. Elevated IGFBP2 expression is present in high-grade glioma and correlates with poor survival. We have previously demonstrated that IGFBP2 induces glioma development and progression in a spontaneous glioma mouse model, which highlighted its significance and potential for future therapy. However, we did not …
